Topline data from the Phase 3 STELLAR-4 trial showed that selonsertib, an investigational treatment for patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH), was not associated with a significant improvement in fibrosis without worsening of NASH.
The Vaccine Injury Compensation Program was developed to offer financial assistance for those harmed by a vaccine.
After primary care patients received invitations in the mail for colorectal cancer screening by fecal immunochemical testing or colonoscopy, results show that more patients invited to screen for colonoscopy switched to FIT.
Endometrial scratching with the use of a pipelle biopsy may not increase live birth rates for women undergoing in vitro fertilization.
The FDA has announced a new plan to significantly modernize the regulation and oversight of dietary supplements.